fMRI reveals plasticity compensating for early dopaminergic loss at corticostriatal synapse
Chiao-Chi Chen1, Yi-Hua Hsu1, Nai-Wei Yao1, and Chen Chang1

1Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan

Synopsis

The dopaminergic system possesses striking plasticity compensating for motor aberrations from neuronal loss. Little is known regarding the compensation mechanism during dopaminergic loss, preventing the aberration from being arrested and treated early. Here we present in vivo imaging evidence from functional magnetic resonance imaging showing that, after dopaminergic depletion, the dorsolateral striatum (DOLS) exhibited an early and transient vasodilation cluster in response to specific forepaw stimulation. Activation of DOLS NMDA receptors causes this vasodilation, protects dopaminergic fibers from denervation, and counteracts motor deficits. The findings have clinical implications for early detection and intervention in brain disorders such as Parkinson’s disease.

Purpose

Upon dopaminergic depletion, both patients with Parkinson’s disease (PD) and experimental animals show behavioral manifestations only with substantial neuronal loss (80~90%)1, 2. Identification and visualization of the adaptive plasticity for dopaminergic injuries remains lacking in the neuroscience literature, with both its location and neurochemical nature being most debated1, 3-10. Functional magnetic resonance imaging (fMRI) can be a useful tool to pinpoint the location and neurochemistry of changes in brain activity11. In this study, a pain-evoked cerebral blood volume (CBV)-weighted fMRI paradigm is used to investigate the crosstalk between the divergent glutamatergic and dopaminergic systems that converge on the striatum, to determine what currently remains unknown regarding the compensatory plasticity upon dopaminergic depletion.

Methods

The rat PD animal model was induced by an intraperitoneal injection of desipramine (15 mg/kg) and then lesioning the right substantia nigra (SN) with 15 mg of 6-hydroxydopamine (6-OHDA) in a volume of 3 ml dissolved in ice-cold 0.02% ascorbic acid. The coordinates for the right SN pars compacta were 5.3 mm posterior, 2.1 mm lateral, and 8.2 mm ventral from the bregma. For measuring the motor deficits, the rats were injected intraperitoneally with methamphetamine (2 mg/kg), and then their rotation behavior was recorded and analyzed. A rat is considered to be parkinsonian when the rotation reaches 360 turns/h. For the day 1 group, the rats received either saline or MK801 via the tail vein at 15 minutes before the administration of methamphetamine. fMRI was conducted using a 4.7-T spectrometer (Biospec 47/40, Bruker, Germany) with a 72-mm-volume coil as the radiofrequency transmitter and a quadrature surface coil as the receiver. For each sensory stimulation evoked fMRI data set, a time series of 60 images were acquired in the axial plane. The first 12, second 12, third 12, fourth 12, and last 12 time frames correspond to the off, on, off, on, and off phases of nociceptive electrical stimulation, respectively, which was delivered to a left or right forepaw via a pair of needle electrodes. Gradient-echo images were acquired in the time series with a repetition time of 150 ms, an echo time of 15 ms, a flip angle of 22.5°, a field of view of 2.56 cm by 2.56 cm, a slice thickness of 1.5 mm, an acquisition matrix of 128×64 (zero-filled to 128×128), and a temporal resolution of 9.6 s. The stimulation intensity was 3 mA or 1 mA, administered by a constant-current stimulator (model 2100, A-M Systems, Carlsborg, WA, USA). The contrast agent was from MegaPro Biomedical Co. Ltd. fMRI correlation maps were generated by the Pearson correlation coefficient (CC) between the image signals and the off–on–off–on–off electrical stimulation paradigm on a voxel-by-voxel basis using the cross-correlation method 12. The cutoff point for the CC was r=±0.2513, 14. NMDAR and D1R antagonism were achieved by MK801 and SKF83566, respectively, injected intravenously during MRI 15 16. The designated administration time point was 5 minutes before the acquisition of a stimulation-evoked fMRI dataset (an off-on-off-on-off stimulation paradigm). After fMRI experiments, the rats were perfused for immunohistology using 4% paraformaldehyde, and the brains were cryosectioned at 50 mm and stained for tyrosine hydroxylase (TH).

Results

When the painful stimulation was applied to the left forepaw of the rats in the early stage after right intranigral 6-OHDA (15µg/Kg) injection, a remarkable novel vasodilation cluster was observed in the DOLS ipsilateral to the lesioned SN at day 1 post-lesion. The DOLS vasodilation is a major sign that marks the difference between the early and late stages of dopamine depletion. The DOLS vasodilation occurs in response to both high intensity (noxious) and low intensity (innoxious) electrical stimulation. Pharmacological testing indicates that the evoked DOLS vasodilation is caused primarily by NMDAR, and secondarily by D1R. When examining the dopaminergic fibers of these brain tissues, we found that the location of the residual dopaminergic fibers coincides with the region exhibiting vasodilation. Moreover, behavioral testing shows that NMDAR antagonism advanced the motor dysfunction of the day 1 rats to a level considered parkinsonism, suggesting that DOLSN activity produces effects compensating for the motor dysfunction in the early stage after dopaminergic depletion.

Conclusions

For the first time, robust evidence is available that indicates an important mechanism to motor compensation upon dopaminergic loss being DOLSN-dependent mediation. In this, the sensory stimulus-evoked CBV-weighted fMRI technique plays an indispensable role in detecting the mechanism. fMRI reveals that DOLSN activity represents the crosstalk between the glutamatergic corticostriatal tracts and dopaminergic nigrostriatal fibers at the convergent synaptic site to cope with the endangered dopaminergic system.

Acknowledgements

No acknowledgement found.

References

1. Zigmond MJ, Abercrombie ED, Berger TW, Grace AA, Stricker EM. Compensations after lesions of central dopaminergic neurons: Some clinical and basic implications. Trends in neurosciences. 1990;13:290-296 2. Lloyd KG. Cns compensation to dopamine neuron loss in parkinson's disease. Advances in experimental medicine and biology. 1977;90:255-266 3. Arkadir D, Bergman H, Fahn S. Redundant dopaminergic activity may enable compensatory axonal sprouting in parkinson disease. Neurology. 2014;82:1093-1098 4. Bezard E, Gross CE, Brotchie JM. Presymptomatic compensation in parkinson's disease is not dopamine-mediated. Trends in neurosciences. 2003;26:215-221 5. Brotchie J, Fitzer-Attas C. Mechanisms compensating for dopamine loss in early parkinson disease. Neurology. 2009;72:S32-38 6. Dreyer JK. Three mechanisms by which striatal denervation causes breakdown of dopamine signaling. J Neurosci. 2014;34:12444-12456 7. Kim SR, Chen X, Oo TF, Kareva T, Yarygina O, Wang C, During M, Kholodilov N, Burke RE. Dopaminergic pathway reconstruction by akt/rheb-induced axon regeneration. Ann Neurol. 2011;70:110-120 8. Lee CS, Samii A, Sossi V, Ruth TJ, Schulzer M, Holden JE, Wudel J, Pal PK, de la Fuente-Fernandez R, Calne DB, Stoessl AJ. In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in parkinson's disease. Ann Neurol. 2000;47:493-503 9. Meurers BH, Dziewczapolski G, Shi T, Bittner A, Kamme F, Shults CW. Dopamine depletion induces distinct compensatory gene expression changes in darpp-32 signal transduction cascades of striatonigral and striatopallidal neurons. J Neurosci. 2009;29:6828-6839 10. Robinson TE, Mocsary Z, Camp DM, Whishaw IQ. Time course of recovery of extracellular dopamine following partial damage to the nigrostriatal dopamine system. J Neurosci. 1994;14:2687-2696 11. Logothetis NK, Pauls J, Augath M, Trinath T, Oeltermann A. Neurophysiological investigation of the basis of the fmri signal. Nature. 2001;412:150-157 12. Bandettini PA, Jesmanowicz A, Wong EC, Hyde JS. Processing strategies for time-course data sets in functional mri of the human brain. Magn Reson Med. 1993;30:161-173 13. Chen CCV, Shih YYI, Chang C. Dopaminergic imaging of nonmotor manifestations in a rat model of parkinson's disease by fmri. Neurobiol Dis. 2013;49:99-106 14. Shih YYI, Chen CCV, Shyu BC, Lin ZJ, Chiang YC, Jaw FS, Chen YY, Chang C. A new scenario for negative functional magnetic resonance imaging signals: Endogenous neurotransmission. J Neurosci. 2009;29:3036-3044 15. Gsell W, Burke M, Wiedermann D, Bonvento G, Silva AC, Dauphin F, Buhrle C, Hoehn M, Schwindt W. Differential effects of nmda and ampa glutamate receptors on functional magnetic resonance imaging signals and evoked neuronal activity during forepaw stimulation of the rat. J Neurosci. 2006;26:8409-8416 16. McLaughlin PJ, Winston KM, Swezey LA, Vemuri VK, Makriyannis A, Salamone JD. Detailed analysis of food-reinforced operant lever pressing distinguishes effects of a cannabinoid cb1 inverse agonist and dopamine d1 and d2 antagonists. Pharmacology, biochemistry, and behavior. 2010;96:75-81

Figures

Figure 1. Pain-evoked CBV-weighted fMRI. The typical CBV response pattern of the normal rat (sham) from the left or right forepaw stimulation. A unique vasodilation was observed in the DOLS only on day1 when the left forepaw was stimulated.

Figure 2. Low intensity electrical stimulation-evoked CBV-weighted fMRI. The unique vasodilation was also observed in the DOLS only on day1 when the left forepaw was stimulated.

Figure 3. The neurochemical nature of the DOLS vasodilation is dominated by NMDA receptor (NMDAR), not D1 receptor (D1R).

Figure 4. The functions of the DOLS NMDAR (DOLSN) activity. (A) DOLS dopaminergic innervations examined by immunohistochemistry against tyrosine hydroxylase. (B) Rotation in the contraversive and ipsiversive directions after methamphetamine over a 100-minute recording session in post-lesion day1 rats treated with saline or the NMDAR antagonist.



Proc. Intl. Soc. Mag. Reson. Med. 24 (2016)
3394